Fingerprint
Dive into the research topics of 'Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai, Russell G. Jones, Ravi K. Amaravadi, Julian J. Lum, Ralph J. DeBerardinis, Fangping Zhao, Benoit Viollet, Craig B. Thompson
Research output: Contribution to journal › Article › peer-review
800
Scopus
citations